153 related articles for article (PubMed ID: 7576950)
1. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
Bjellerup P; Theodorsson E; Kogner P
Eur J Cancer; 1995; 31A(4):481-5. PubMed ID: 7576950
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin in neuroblastoma and ganglioneuroma.
Kogner P; Borgström P; Bjellerup P; Schilling FH; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
Eur J Cancer; 1997 Oct; 33(12):2084-9. PubMed ID: 9516858
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.
Kogner P; Bjellerup P; Svensson T; Theodorsson E
Eur J Cancer; 1995; 31A(4):557-60. PubMed ID: 7576967
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
Kogner P; Björk O; Theodorsson E
Med Pediatr Oncol; 1993; 21(5):317-22. PubMed ID: 8492745
[TBL] [Abstract][Full Text] [Related]
6. Vasocative intestinal polypeptide (VIP)-producing ganglioneuroma in a child with chronic diarrhea.
Hansen LP; Lund HT; Fahrenkrug J; Søgaard H
Acta Paediatr Scand; 1980 May; 69(3):419-24. PubMed ID: 7376870
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
Quak SH; Prabhakaran K; Kwok R; O'Reilly AP
Aust Paediatr J; 1988 Feb; 24(1):55-8. PubMed ID: 2833214
[TBL] [Abstract][Full Text] [Related]
8. PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP.
Fahrenkrug J; Buhl T; Hannibal J
Regul Pept; 1995 Aug; 58(3):89-98. PubMed ID: 8577931
[TBL] [Abstract][Full Text] [Related]
9. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.
Tiedemann K; Pritchard J; Long R; Bloom SR
Eur J Pediatr; 1981 Oct; 137(2):217-9. PubMed ID: 6118274
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and vasoactive intestinal polypeptide-like immunoreactive cells and terminals in the retrohippocampal region of the rat brain.
Köhler C; Chan-Palay V
Anat Embryol (Berl); 1983; 167(2):151-72. PubMed ID: 6137169
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus.
Gomariz RP; Lorenzo MJ; Cacicedo L; Vicente A; Zapata AG
Brain Behav Immun; 1990 Jun; 4(2):151-61. PubMed ID: 1975506
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
Takahashi K; Mouri T; Itoi K; Sone M; Hayashi Y; Murakami O; Ohneda M; Ohi R; Yoshinaga K
Endocrinol Jpn; 1989 Oct; 36(5):627-33. PubMed ID: 2620662
[TBL] [Abstract][Full Text] [Related]
13. Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas.
El Shafie M; Samuel D; Klippel CH; Robinson MG; Cullen BJ
J Pediatr Surg; 1983 Feb; 18(1):34-6. PubMed ID: 6834224
[TBL] [Abstract][Full Text] [Related]
14. Regulatory peptides in neuronal neoplasms of the central nervous system.
Giangaspero F; Burger PC; Budwit DA; Usellini L; Mancini AM
Clin Neuropathol; 1985; 4(3):111-5. PubMed ID: 2861927
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide-like immunoreactivity in a human neuroblastoma cell line and the coexistence of other neuropeptide immunoreactivity in the cell line.
Yanaihara N; Kobayashi S; Sato H; Yanaihara C; Sakagami M; Sakura N; Hashimoto T; Ishikawa S; Iwanaga T; Fujita T
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():37-42. PubMed ID: 6164547
[TBL] [Abstract][Full Text] [Related]
16. Tumor with watery diarrhoea, hypokalaemia in a 3-year-old girl.
Zhang WQ; Liu JF; Zhao J; Zhao SY; Xue Y
Eur J Pediatr; 2009 Jul; 168(7):859-62. PubMed ID: 19101728
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat.
Grupcev G; Wallin C; Emås S; Theodorsson E; Hellström PM
Regul Pept; 1994 Jul; 52(2):111-8. PubMed ID: 7972934
[TBL] [Abstract][Full Text] [Related]
18. Co-existence and co-secretion of the structurally related peptides VIP and PHI.
Fahrenkrug J
Scand J Clin Lab Invest Suppl; 1987; 186():43-50. PubMed ID: 3474771
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.
Qualman SJ; O'Dorisio MS; Fleshman DJ; Shimada H; O'Dorisio TM
Cancer; 1992 Oct; 70(7):2005-12. PubMed ID: 1381992
[TBL] [Abstract][Full Text] [Related]
20. The response of a non-functional VIP- and somatostatin-containing tumour to tolbutamide in vitro.
Woltering EA; O'Dorisio TM; Mekhjian HS; Ellison EC; Dyben T; Howe BA; Tuttle SE; Minton JP
Scand J Gastroenterol Suppl; 1986; 119():129-35. PubMed ID: 2876496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
